Celgene Corporation total revenue, net income and dynamics of changes in US dollar today
Net revenue of Celgene Corporation on 30/09/2019 amounted to 4 520 000 000 $. The dynamics of net revenue of Celgene Corporation rose. The change amounted to 120 000 000 $. The dynamics of net revenue is shown in comparison with the previous report. The dynamics of Celgene Corporation net income rose by 120 000 000 $. The assessment of the dynamics of Celgene Corporation net income was made in comparison with the previous report. The financial report chart on our website displays information by dates from 30/06/2017 to 30/09/2019. Celgene Corporation financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Celgene Corporation total revenue on the graph is shown in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/09/2019
4 520 000 000 $
+16.14 % ↑
1 691 000 000 $
+56.28 % ↑
30/06/2019
4 400 000 000 $
+15.36 % ↑
1 571 000 000 $
+50.33 % ↑
31/03/2019
4 025 000 000 $
+13.76 % ↑
1 545 000 000 $
+82.62 % ↑
31/12/2018
4 037 000 000 $
+15.91 % ↑
1 073 000 000 $
-
30/09/2018
3 892 000 000 $
-
1 082 000 000 $
-
30/06/2018
3 814 000 000 $
-
1 045 000 000 $
-
31/03/2018
3 538 000 000 $
-
846 000 000 $
-
31/12/2017
3 483 000 000 $
-
-81 000 000 $
-
30/09/2017
3 287 000 000 $
-
988 000 000 $
-
30/06/2017
3 268 000 000 $
-
1 061 000 000 $
-
Show:
to
Celgene Corporation financial report charts
The latest dates of Celgene Corporation financial statements available online: 30/06/2017, 30/06/2019, 30/09/2019. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of Celgene Corporation is 30/09/2019. Gross profit Celgene Corporation is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Celgene Corporation is 4 163 000 000 $
Celgene Corporation quarterly report dates
Cost of revenue Celgene Corporation is the total cost of producing and distributing of products and services of a company. Cost of revenue Celgene Corporation is 357 000 000 $ Total revenue Celgene Corporation refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Celgene Corporation is 4 520 000 000 $ Operating revenue Celgene Corporation is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Celgene Corporation is 4 520 000 000 $
Operating income Celgene Corporation is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Celgene Corporation is 2 296 000 000 $ Net income Celgene Corporation is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Celgene Corporation is 1 691 000 000 $ Current assets Celgene Corporation is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Celgene Corporation is 14 454 000 000 $
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
4 163 000 000 $
4 149 000 000 $
3 656 000 000 $
3 662 000 000 $
3 723 000 000 $
3 521 000 000 $
3 403 000 000 $
3 364 000 000 $
3 169 000 000 $
3 157 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
357 000 000 $
251 000 000 $
369 000 000 $
375 000 000 $
169 000 000 $
293 000 000 $
135 000 000 $
119 000 000 $
118 000 000 $
111 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
4 520 000 000 $
4 400 000 000 $
4 025 000 000 $
4 037 000 000 $
3 892 000 000 $
3 814 000 000 $
3 538 000 000 $
3 483 000 000 $
3 287 000 000 $
3 268 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
4 520 000 000 $
4 400 000 000 $
4 025 000 000 $
4 037 000 000 $
3 892 000 000 $
3 814 000 000 $
3 531 000 000 $
3 479 000 000 $
3 283 000 000 $
3 256 000 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
2 296 000 000 $
2 247 000 000 $
1 787 000 000 $
1 782 000 000 $
1 888 000 000 $
1 570 000 000 $
249 000 000 $
-227 000 000 $
1 134 000 000 $
1 295 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 691 000 000 $
1 571 000 000 $
1 545 000 000 $
1 073 000 000 $
1 082 000 000 $
1 045 000 000 $
846 000 000 $
-81 000 000 $
988 000 000 $
1 061 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
977 000 000 $
1 000 000 000 $
987 000 000 $
992 000 000 $
1 069 000 000 $
1 084 000 000 $
2 203 000 000 $
2 738 000 000 $
1 347 000 000 $
835 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 224 000 000 $
2 153 000 000 $
2 238 000 000 $
2 255 000 000 $
2 004 000 000 $
2 244 000 000 $
3 154 000 000 $
3 591 000 000 $
2 035 000 000 $
1 862 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
14 454 000 000 $
12 683 000 000 $
10 981 000 000 $
9 067 000 000 $
7 827 000 000 $
6 853 000 000 $
7 872 000 000 $
14 892 000 000 $
14 783 000 000 $
13 136 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
41 363 000 000 $
39 183 000 000 $
37 639 000 000 $
35 480 000 000 $
34 215 000 000 $
33 444 000 000 $
34 556 000 000 $
30 141 000 000 $
31 736 000 000 $
30 306 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
9 604 000 000 $
7 214 000 000 $
5 433 000 000 $
4 234 000 000 $
2 480 000 000 $
1 503 000 000 $
2 819 000 000 $
7 013 000 000 $
5 511 000 000 $
6 660 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
5 009 000 000 $
3 685 000 000 $
3 955 000 000 $
4 057 000 000 $
3 683 000 000 $
4 502 000 000 $
-
-
1 400 000 000 $
500 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
4 740 000 000 $
12 042 000 000 $
11 759 000 000 $
10 140 000 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
29 276 000 000 $
29 132 000 000 $
29 474 000 000 $
29 319 000 000 $
29 355 000 000 $
30 014 000 000 $
-
-
14 274 000 000 $
14 283 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
70.78 %
74.35 %
78.31 %
82.64 %
85.80 %
89.74 %
-
-
44.98 %
47.13 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
12 087 000 000 $
10 051 000 000 $
8 165 000 000 $
6 161 000 000 $
4 860 000 000 $
3 430 000 000 $
5 172 000 000 $
6 921 000 000 $
9 850 000 000 $
8 445 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
2 172 000 000 $
2 167 000 000 $
1 476 000 000 $
2 343 000 000 $
1 924 000 000 $
1 229 000 000 $
-325 000 000 $
1 689 000 000 $
1 088 000 000 $
1 616 000 000 $
Last revenue report of Celgene Corporation was 30/09/2019. According to last financial report total revenue in Celgene Corporation was 4 520 000 000 US dollar and changed by +16.14% since last year. Net income in Celgene Corporation was 1 691 000 000 $ in last quartal, net income changes to +56.28%.
Total assets Celgene Corporation refers to the total amount of assets owned by a person or entity. Total assets Celgene Corporation is 41 363 000 000 $ Current cash Celgene Corporation - the sum of all of the cash a company has on the date of report. Current cash Celgene Corporation is 9 604 000 000 $ Current debt Celgene Corporation is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Celgene Corporation is 5 009 000 000 $
